Purpose: To determine whether wide-volume perfusion computed tomography (CT) performed with a new generation scanner can allow evaluation of the effects of chemotherapy combined with antiangiogenetic treatment on the whole tumor mass in patients with locally advanced lung adenocarcinoma and to determine if changes in CT numbers correlate with the response to therapy as assessed by conventional response evaluation criteria in solid tumors (RECIST). Materials and Methods: Forty-five patients with unresectable lung adenocarcinoma underwent perfusion CT before and 40 and 90 days after chemotherapy and antiangiogenetic treatment. RECIST measurements and calculations of blood flow, blood volume, time to peak, and permeability were performed by two independent blinded radiologists. Pearson correlation coefficient was used to assess the correlation between baseline CT numbers. Baseline and follow-up perfusion parameters of the neoplastic lesions were tested overall for statistically significant differences by using the repeated-measures analysis of variance and then were also compared on the basis of the therapy response assessed according to the RECIST criteria. Results: Pearson correlation coefficient showed a significant correlation between baseline values of blood flow and blood volume (rho = 0.48; P = .001), time to peak and permeability (rho = 0.31; P = .04), time to peak and blood flow (rho = -0.66; P < .001), and time to peak and blood volume (rho = -0.39; P = .007). Blood flow, blood volume, and permeability values were higher in responding patients than in the other patients, with a significant difference at second follow-up for blood flow (P = .0001), blood volume (P = .02), and permeability (P = .0001); time to peak was higher in non-responding patients (P = .012). Conclusion: Perfusion CT imaging may allow evaluation of lung cancer angiogenesis demonstrating alterations in vascularity following treatment. (C)RSNA, 2011

Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy : Initial experience / Francesco, Fraioli; Michele, Anzidei; Fulvio, Zaccagna; Maria Luisa, Mennini; Goffredo, Serra; Bruno, Gori; Flavia, Longo; Catalano, Carlo; Roberto, Passariello. - In: RADIOLOGY. - ISSN 0033-8419. - 259:2(2011), pp. 574-582. [10.1148/radiol.11100600]

Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy : Initial experience

CATALANO, Carlo;
2011

Abstract

Purpose: To determine whether wide-volume perfusion computed tomography (CT) performed with a new generation scanner can allow evaluation of the effects of chemotherapy combined with antiangiogenetic treatment on the whole tumor mass in patients with locally advanced lung adenocarcinoma and to determine if changes in CT numbers correlate with the response to therapy as assessed by conventional response evaluation criteria in solid tumors (RECIST). Materials and Methods: Forty-five patients with unresectable lung adenocarcinoma underwent perfusion CT before and 40 and 90 days after chemotherapy and antiangiogenetic treatment. RECIST measurements and calculations of blood flow, blood volume, time to peak, and permeability were performed by two independent blinded radiologists. Pearson correlation coefficient was used to assess the correlation between baseline CT numbers. Baseline and follow-up perfusion parameters of the neoplastic lesions were tested overall for statistically significant differences by using the repeated-measures analysis of variance and then were also compared on the basis of the therapy response assessed according to the RECIST criteria. Results: Pearson correlation coefficient showed a significant correlation between baseline values of blood flow and blood volume (rho = 0.48; P = .001), time to peak and permeability (rho = 0.31; P = .04), time to peak and blood flow (rho = -0.66; P < .001), and time to peak and blood volume (rho = -0.39; P = .007). Blood flow, blood volume, and permeability values were higher in responding patients than in the other patients, with a significant difference at second follow-up for blood flow (P = .0001), blood volume (P = .02), and permeability (P = .0001); time to peak was higher in non-responding patients (P = .012). Conclusion: Perfusion CT imaging may allow evaluation of lung cancer angiogenesis demonstrating alterations in vascularity following treatment. (C)RSNA, 2011
2011
Adenocarcinoma; Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Female; Humans; Iopamidol; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Tomography, X-Ray Computed; Radiology, Nuclear Medicine and Imaging
01 Pubblicazione su rivista::01a Articolo in rivista
Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy : Initial experience / Francesco, Fraioli; Michele, Anzidei; Fulvio, Zaccagna; Maria Luisa, Mennini; Goffredo, Serra; Bruno, Gori; Flavia, Longo; Catalano, Carlo; Roberto, Passariello. - In: RADIOLOGY. - ISSN 0033-8419. - 259:2(2011), pp. 574-582. [10.1148/radiol.11100600]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/379995
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 87
  • ???jsp.display-item.citation.isi??? 73
social impact